WCMC logo
PMKB
  • WCMC logoPMKB
  • Genes
  • Variants
  • Interpretations
  • Tumor Types
  • Primary Sites
  • Activity
  • Login
ATM
  • Information
  • View History
  • Pending Review
ATM F858L
GeneATM
Variantmissense
Amino Acid ChangeF858L
Transcript ID (GRCh37/hg19)ENST00000278616
Codon858
Exon17
Germline/Somatic?Somatic
Pertinent Negative In
Tumor TypePrimary Site
See All Pertinent Negatives

Interpretations

Sort by
Page
Show

Tier 3
ATM
Variants
ATM P604S
ATM A1309T
ATM F858L
Primary Sites
Thyroid
Tumor Types
Papillary Carcinoma
Interpretation

ATM alterations have been reported as germline variants which predispose to inherited cancer syndromes and as somatic (acquired) variants in tumors. ATM is part of many signalling networks, including cell metabolism and growth, oxidative stress, and chromatin remodelling, all of which can affect cancer progression. Although ATM is rightly considered to be a tumour suppressor, ATM signalling can also be advantageous to cancer cells, particularly in resistance to radio- and chemotherapeutic treatment. For this reason, ATM inhibitors have been developed for use in cancer therapy.

Last updated: 2016-06-07 01:52:16 UTC
Read More
Tier 3
ATM
Variants
ATM P604S
ATM A1309T
ATM F858L
Primary Sites
Skin
Breast
Tumor Types
Melanoma
Interpretation

ATM alterations have been reported as germline variants which predispose to inherited cancer syndromes and as somatic (acquired) variants in tumors, including breast cancer. ATM is part of many signalling networks, including cell metabolism and growth, oxidative stress, and chromatin remodelling, all of which can affect cancer progression. Although ATM is rightly considered to be a tumour suppressor, ATM signalling can also be advantageous to cancer cells, particularly in resistance to radio- and chemotherapeutic treatment. For this reason, ATM inhibitors have been developed for use in cancer therapy.

Last updated: 2016-06-07 01:48:50 UTC
Read More
Tier 3
ATM
Variants
ATM F858L
Primary Sites
Ampulla (Pancreaticobiliary Duct)
Tumor Types
Adenocarcinoma
Interpretation

ATM is a member of the protein superfamily of phosphatidylinositol 3-kinase related serine/threonine kinases (PIKKs). ATM is part of many signaling networks, including cell metabolism and growth, oxidative stress, and chromatin remodeling, all of which can affect cancer progression. Although ATM is considered to be a tumor suppressor, ATM signaling may be advantageous to cancer cells in some settings, particularly in resistance to radio- and chemotherapeutic treatment. Germline ATM mutations are the defining feature of ataxia telangiectasia syndrome, a rare, neurodegenerative, autosomal disorder. ATM somatic mutations are associated with endometrial, colon, pancreatic, breast cancers and urothelial cancers. ATM-mutant cancers are increasingly sensitive to DNA damaging agents due to deficits in DNA repair pathways, and ATM loss may result in better response to checkpoint inhibition in some cancers. For this reason, the use of ATM inhibitors in cancer therapy is under exploration. Genetic alterations of ATM have been identified in 5% of pancreatic adenocarcinomas. ATM F858L has been identified in the scientific literature, but has not been biochemically characterized and therefore, its effect on ATM protein function is unknown. According to ClinVar, this variant is considered to be a benign/likely benign germline variant (https://preview.ncbi.nlm.nih.gov/clinvar/variation/132736/). Clinical correlation is recommended.

Last updated: 2019-01-22 18:44:03 UTC
Read More
Tier 3
ATM
Variants
ATM P604S
ATM A1309T
ATM F858L
ATM P2699S
Primary Sites
Lung
Breast
Colon
Rectum
Unknown
Esophagus
Stomach
Tumor Types
Adenocarcinoma
Interpretation

ATM alterations have been reported as germline variants which predispose to inherited cancer syndromes and as somatic (acquired) variants in tumors. ATM is part of many signalling networks, including cell metabolism and growth, oxidative stress, and chromatin remodelling, all of which can affect cancer progression. Although ATM is considered to be a tumour suppressor, ATM signaling may be advantageous to cancer cells in some settings, particularly in resistance to radio- and chemotherapeutic treatment. For this reason, the use of ATM inhibitors in cancer therapy is under exploration.

Last updated: 2019-01-22 18:50:49 UTC
Read More
PMKB Bot
  • Genes
  • Variants
  • Interpretations
  • Tumor Types
  • Primary Sites
  • Activity

Disclaimer: You assume full responsibility for all risks associated with using this PMKB website. The Englander Institute for Precision Medicine at Weill Cornell Medicine makes no guarantee of the comprehensiveness, reliability or accuracy of the information on this website and assumes no responsibility for errors in the information associated with this web site. Healthcare providers and patients must integrate all clinical and laboratory findings as well as information from a variety of sources before deciding on appropriate clinical care options.


When using PMKB, please cite: Huang et al., JAMIA 2017


HELP
User Guide
Video Tutorial
INFO
About
Latest
API
Twitter
CONTACT US
Contact

Englander Institute for Precision Medicine
© Weill Cornell Medicine | Version 1.7.2Privacy PolicyTerms of use